Jeffrey W. Miller

Endocrinology

1415 E Kincaid St
Mount Vernon, WA 98274

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

NEO6860, modality-selective TRPV1 antagonist: a randomized, controlled, proof-of-concept trial in patients with osteoarthritis knee pain.

NEO6860, modality-selective TRPV1 antagonist: a randomized, controlled, proof-of-concept trial in patients with osteoarthritis knee pain.

Journal: Pain reports

Published: June 11, 2018

Showing 1-1 of 1

Last Updated: 09/26/2026